Depot systems comprising glatiramer or pharmacologically acceptable salt thereof

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO RE50301
SERIAL NO

17894447

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Long acting parenteral pharmaceutical compositions comprising a therapeutically effective amount of glatiramer are provided. In particular, the present invention provides a long acting pharmaceutical composition comprising a therapeutically effective amount of glatiramer acetate in depot form suitable for administering at a medically acceptable location in a subject in need thereof. The depot form is suitable for subcutaneous or intramuscular implantation or injection.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MAPI PHARMA LTD16 EINSTEIN STREET WEIZMANN SCIENCE PARK P O BOX 4113 NESS ZIONA 74140

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Marom, Ehud Tel Aviv, IL 45 110
Rubnov, Shai Tel Aviv, IL 32 75

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Aug 18, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 18, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 18, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00